Skip to main content
. Author manuscript; available in PMC: 2015 Oct 7.
Published in final edited form as: Chem Soc Rev. 2015 Jun 9;44(17):6258–6286. doi: 10.1039/c4cs00511b

Figure 10.

Figure 10

Nanotheranostics of CTCs in the lymphatic circulation system with multifunctional dual-targeting nanomedicines. The dual-targeting nanomedicines can be engineered to target lymphatic nodes (LNs) and enter the lymphatic circulation system firstly, and then target the CTCs in the lymphatic circulation system. The dual-targeting will enable the diagnosis and responsive therapy of CTCs in the lymphatic circulation system.